Periodic Reporting for period 1 - reMARK-AML (Re-envisioning risk biomarkers in acute myeloid leukemia (AML) at single-cell level)

Acute myeloid leukemia (AML) is one of the most aggressive hematological malignancies that despite recent progresses remains an unmet medical need. Genetic markers are used to define different disease categories and prognostic groups. One of the most frequent is mutations in...